By GREGORY ZELLER // The National Institutes of Health is backing an early-stage Kings Park biotech’s quest for non-antibiotic-based COVID-19 treatments. CMTx Biotech has non-antimicrobials in its sights and a…
By GREGORY ZELLER // Innovation abounds among the 15 Stony Brook University faculty members being welcomed today into the National Academy of Inventors. The national academy’s SBU chapter, which debuted…
By GREGORY ZELLER // The National Institutes of Health has welcomed a rising Stony Brook biotech into its competitive Commercialization Accelerator Program. Traverse Biosciences, which is attempting to commercialize novel…
By GREGORY ZELLER // When a new U.S. patent is your second-biggest announcement of the day, you’re probably in a good place. It’s all smiles (with healthy teeth, of course)…
By GREGORY ZELLER // First, healthy teeth for dogs … then a cancer cure for the world? Financially and otherwise, Traverse Biosciences enjoyed a strong 2016 – but it may…
BY GREGORY ZELLER // Stony Brook-based startup Traverse Biosciences has inked an exclusive R&D agreement that could lead to an $8 million sublicensing option. Traverse, a resident of the Long…